Family-Based Financial Incentives Intervention for Smoking Cessation
ConditionSmoking Cessation
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMayo Clinic
About this trial
The current study will conduct an RCT to evaluate the effectiveness of a family-based incentive intervention with Alaska Native/American Indian families. The experimental arm will be compared to a control arm on biochemically-confirmed smoking abstinence at 6- and 12-months post-intervention.
Eligibility criteria
Qualifiers
Alaska Native/American Indian (ANAI) person (based on self-reported race) and reside in Alaska.
Age ≥18 years.
Self-report smoking in the past 7 days, biochemically verified with saliva cotinine ≥ 30 ng/mL (positive result based on at-home saliva swab test provided by study team).
Smoked ≥ 3 cigarettes per day over the past 3 months.
Disqualifiers
Already enrolled in the study with another family member.
Participated in a prior study phase.
Age ≥18 years.
Defined as family and nominated by the index participant, or have an ANAI family member who is ≥18 years and smokes that they would like to support in quitting.
Trial design
Treatments tested in this trial
- Financial Incentive Rewards
Treatment groups
1,312 Participants
are divided into 2 treatment groupsSponsors and collaborators
Mayo Clinic
Lead sponsor
National Institute on Drug Abuse (NIDA)
Collaborator
Alaska Native Tribal Health Consortium
Collaborator
Source ClinicalTrials.gov